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1. Introduction 
Adenyl cyclase has been found in several bacterial 
species and many higher organisms [I]. The enzyme 
from Metazoa is activated by sodium fluoride and a 
wide variety of hormones, whilst the adenyl cyclase 
of Brevibacterium liquifaciens requires pyruvate as a 
cofactor [2] and that of Escherichia coli is inhibited 
by sodium fluoride [3]. 
To our knowledge the formation of 3’,5’ cyclic 
AMP has not previously been shown in protozoa. The 
findings of Blum [4] that aminophylline increased 
the glycogen synthetase activity of Tetrahymena can 
be explained by assuming that this drug elevated the 
level of 3’,5’ cyclic AMP in the cells. 
It was thus of interest to examine the adenyl 
cyclase activity in the ciliate Tetrahymena pyriformis. 
We report here the activation of this enzyme by 
epinephrine, serotonin and NaF. The abolition of the 
epinephrine stimulation by propranolol but not 
phentolamine indicates strongly that the activity of 
this neurohormone is mediated through a fl type 
adrenergic receptor. 
2. Materials and methods 
2.1. Enzyme preparation 
Tetrahymena pyriformis strain W, was grown in a 
medium containing 2% proteose peptone (Difco), 
0.1% yeast extract (Difco) and 5 pg/ml FeCIJ - 6Hz 0, 
in Roux bottles. After 48 hr growth at 28’, cells from 
100 ml of the culture were centrifuged at 4300 g for 
10 min and washed three times in 0.15 M KCI. The 
cells were then resuspended in 5 ml of 0.25 M sucrose, 
disrupted in a Branson Sonifier B12 for 1 min at 
setting 6, and centrifuged at 61Og for 10 min. The 
precipitate containing mostly membranes was suspend- 
ed in 1.5 ml of 0.24 M Tris buffer pH 7.3 and used as 
a source of enzymatic activity. All operations were 
performed at 4”. 
2.2. Assay of adenyl cyclase activity 
The assay system contained: 40 mM Tris-HCl, pH 
7.3; 3.3 mM MgClz ; 10 mM caffein; 1 mM [3H]ATP 
(1 /..&i per pmole) and 0.1 ml of enzyme preparation 
in a final volume of 0.7 ml. The incubation was at 
30” for 30 min unless otherwise stated. The reaction 
was stopped by immersion in a boiling water bath for 
3 min. The amount of 3H-labelled cyclic AMP was 
measured according to a slightly modified procedure 
of Krishna et al. [5]. 
Scintillation counting of 3H-labelled cyclic AMP 
.was performed in Bray solution using Packard Tricarb 
scintillation spectrometer. [3H]ATP (18.3 Ci/mmole) 
was obtained from Schwartz. Epinephrine, norepineph- 
rine and serotonin were from Sigma. Other materials 
were of the highest analytical grade available. Protein 
was estimated by the procedure of Lowry et al. 161, 
using bovine serum albumin as standard. 
3. Results and discussion 
The adenyl cyclase activity of T. pyrifomzis, was 
found to be associated with the membrane fraction 
obtained after low speed centrifugation of sonicated 
cells, as has been found in other organisms. The activ- 
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Fig. 1. Time course of adenyl cyclase activity in the presence 
of 10 mM sodium fluoride. 
ity was dependent on the addition of Mg*’ and either 
caffein or aminophylline. The effect of caffein was 
due to inhibition of a potent phosphodiesterase pre- 
sent in these preparations. 
Little activity was observed in the absence of NaF, 
whilst in its presence a linear response with time was 
obtained for at least 45 min (fig. 1). Since T. pyriform- 
is is known to synthesize epinephrine, norepinephrine 
Table 1 
Activation of T. pyriformis adenyl cyclase. 
Addition to and omission 
from incubation system 
Adenyl cyclase 
specific activity 
(cyclic AMP formed) 
(nmoles/mg 
protein/30 min)* 
None 1.9 
Plus 10 mM NaF 6.3 
Plus 1 mM epinephrine 7.8 
Plus 1 mM norepinephrine 0.4 
Plus 10 mM NaF minus MgZ+ 1.9 
Plus 10 mM NaF minus caffein 0.6 
* Mean values of at least two experiments. 
Table 2 
Effect of adrenergic blocking agents on stimulation of T. 
-._ 
pyriformis adenyl cyclase. 
-- 
Adenyl cyclase 
specific activity 
Addition to incubation system (cyclic AMP formed)* 
10 PM Epinephrine 5.1 
10 @M Epinephrine + 
10 PM propranolol 0.6 
10 PM Epinephrine + 
10 ).IM phentolamine 4.9 
1 mM NaF 4.7 
1 mM NaF + 1 mM propranolol 5.1 
1 mM NaF + 1 mM phentolamine 5.6 
1 mM Serotonin 6.0 
1 mM Serotonin + 1 mM propranolol 5.5 
1 mM Serotonin + 1 mM phentolamine 5.9 
* Mean values of at least two experiments. 
[7] and serotonin [8], these neurohormones were 
tested for stimulation of cyclase activity. Epinephrine 
(1 mM) was even more effective than NaF (10 mM) 
in stimulating the cyclase activity. On the other hand, 
norepinephrine (1 mM) had no effect, and even seemed 
to inhibit the unstimulated activity (table 1). The 
stimulation by epinephrine could be abolished by the 
/3-adrenergic blocking agent, propranolol, but not by 
the ac-adrenergic blocker phentolamine (table 2). Like 
in other systems described propranolol had no effect 
on the stimulation produced by fluoride. The lower 
activity in the presence of epinephrine and propranolol 
than in the absence of any additions indicates that 
endogenous epinephrine was present in the preparations. 
The cyclase activity was also increased by serotonin; 
its stimulation was lower than that caused by epineph- 
rine but higher than that of fluoride. The comparison 
of the dose-response ffect of NaF, epinephrine and 
serotonin is presented in fig. 2. The serotonin activa- 
tion was not inhibited by either propranolol or by 
phentolamine at equimolar concentrations. Serotonin 
was shown to enhance adenyl cyclase mediated reac- 
tions in such diverse organisms as the liver fluke [9] 
and rabbit [lo], but no direct effect on the cyclase 
in vitro was reported. 
The inhibition of the growth of Tetrahymena by 
both (Y and /I adrenergic blocking agents was shown 
by Bloom [ 111. However, on the basis of these exper- 
iments it was not possible to decide whether the 
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Fig. 2. Effect of the concentration of stimulatory substances 
on the activity of adenyl cyclase of T. pyrifonnis. (0 - 0) 
Epinephrine; (o - o) serotonin; (4 - A) NaF. 
inhibition was related to adrenergic sites or to other 
growth controlling systems [ 121. Our results support 
strongly the hypothesis that adenyl cyclase in T. 
pyrifonnis is activated by epinephrine through a fl- 
type receptor. Thus growth inhibition by propranolol 
can be related to distorted metabolic control due to 
inhibition of the P-receptor. 
These observations may allow us to assign a function 
to the presence of epinephrine and serotonin in 
Tetrahymena, viz. as activators of CAMP synthesis. As 
pointed out by Janakidevi et al. [7], the ultimate role 
of these substances may be in the regulation of 
polysaccharide reserve, particularly as this ciliate has 
a large store of glycogen. However, since cyclic AMP 
is important in many reactions, the activation of its 
synthesis probably has also other functions. 
The relative ease of growing T. pyriformis and a 
uniform cell population under defined conditions, 
should facilitate greatly the purification and further 
characterization of the P-like adrenergic receptor. 
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